Literature DB >> 26182934

Serum activities of liver enzymes in workers exposed to sub-TLV levels of dimethylformamide.

Jinjiang He1, Jie Liu2, Yulin Kong2, Weiwei Yang3, Zengli Zhang4.   

Abstract

OBJECTIVES: The aim of this study has been to investigate serum activities of liver enzymes in workers exposed to sub-TLV levels of dimethylformamide (DMF).
MATERIAL AND METHODS: Seventy-two workers and 72 healthy controls participated in the study. All subjects underwent complete physical examinations and abdominal ultrasound examination. Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and c-glutamyl transpeptidase (c-GT) were determined by an auto-chemistry analyzer. The data of airborne concentrations of DMF was obtained from the local Center of Disease Control and Prevention. The level of urine N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) was measured by means of high-performance liquid chromatography.
RESULTS: Time weighted average (TWA) concentration of the DMF in workplace was 18.6 (range: 9.8-36.2) mg/m<sup>3</sup>. The concentration of the AMCC in workers' urine was 28.32 (range: 1.8-58.6) mg/l and 9 workers' AMCC exceeded the biological exposure index (40 mg/l). Thirty-one workers reported gastrointestinal symptoms (abdominal pain, nausea, anorexia) and 10 workers reported headache, dizziness and/or palpitation in the exposed group. Serum analysis revealed that both the mean of serum activities of liver enzymes (ALT, AST and c-GT) and the percentage of workers with abnormal liver function were significantly higher in the exposed group as compared to the controls.
CONCLUSIONS: Dimethylformamide can cause liver damage even if air concentration is in the sub-threshold limit value (sub-TLV) level. The protection of skin contact against the exposure to the DMF might be a critical issue as far as the occupational health is concerned. This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Entities:  

Keywords:  TWA; dimethylformamide; liver enzymes; sub-TLV; urine; workers

Mesh:

Substances:

Year:  2015        PMID: 26182934     DOI: 10.13075/ijomeh.1896.00086

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  4 in total

1.  Association between CYP2E1 and GOT2 gene polymorphisms and susceptibility and low-dose N,N-dimethylformamide occupational exposure-induced liver injury.

Authors:  Haiyue Jiang; Xiaoyue Zhang; Jiayang Shen; Yu Zhang; Yiyang Gu; Tian Tian; Minjie Chu; Xun Zhuang; Yulong Lian
Journal:  Int Arch Occup Environ Health       Date:  2019-04-16       Impact factor: 3.015

2.  Prioritizing Type of Industry through Health Risk Assessment of Occupational Exposure to Dimethylformamide in the Workplace.

Authors:  Junghyun Lee; Miran Hahm; Da-An Huh; Sang-Hoon Byeon
Journal:  Int J Environ Res Public Health       Date:  2018-03-13       Impact factor: 3.390

3.  Genetic Variations in the Promoter of the APE1 Gene Are Associated with DMF-Induced Abnormal Liver Function: A Case-Control Study in a Chinese Population.

Authors:  Zhimin Tong; Huanxi Shen; Dandan Yang; Feng Zhang; Ying Bai; Qian Li; Jian Shi; Hengdong Zhang; Baoli Zhu
Journal:  Int J Environ Res Public Health       Date:  2016-07-25       Impact factor: 3.390

4.  The effects of dimethylformamide exposure on liver and kidney function in the elderly population: A cross-sectional study.

Authors:  Zhi-Yong Hu; Jie Chang; Fei-Fei Guo; Han-Yi Deng; Guo-Tao Pan; Bing-Yan Li; Zeng-Li Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.